Source: FinanzNachrichten

Vivasure: TCT 2024: Vivasure Medical to Unveil US Pivotal Data for PerQseal Elite Vascular Closure System

Lead Investigators of the Multi-Center PATCH, ELITE and ELITE Venous Studies to Discuss Outcomes Technology designed to change the way cardiologists perform large hole closure for structural inter...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Andrew Glass's photo - CEO of Vivasure

CEO

Andrew Glass

CEO Approval Rating

90/100

Read more